IRVINE, Calif., March 19, 2009 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced its entry into the China market, further extending its presence in the global market. In addition to currently selling its products in more than 30 countries, SenoRx has begun marketing EnCor(r), its vacuum-assisted breast biopsy product, and its GelMark(tm) line of breast biopsy tissue markers through its distribution partner, Beijing Eastwide Medical Ltd (BJEW).
